U.S. Medical Equipment Stock News

BrightSpring Health Services (NasdaqGS:BTSG) is reallocating capital toward acquisitions and organic growth in its core home and clinical services. The company is accelerating de-leveraging efforts to increase financial flexibility. BrightSpring plans to divest its community-living operations, with the transaction expected to close soon. BrightSpring operates in home and clinical care, an area that sits at the intersection of aging demographics, pressure on institutional care settings, and...

The Buckle, Inc. has already reported its fourth quarter and full-year results for the period ended January 31, 2026, with quarterly sales of US$399.14 million and net income of US$80.85 million, and full-year sales of US$1.30 billion and net income of US$209.74 million, all higher than the prior year. These results also lifted basic earnings per share from continuing operations to US$1.60 for the quarter and US$4.17 for the year, suggesting Buckle converted its sales growth into stronger...

Fresh Del Monte Produce (NYSE:FDP) has completed the acquisition of key assets and global brand rights from Del Monte Foods Corporation II Inc. The transaction reunites the Del Monte brand under a single owner for the first time in nearly forty years. The deal consolidates worldwide control of the Del Monte name, covering both fresh and packaged products. Fresh Del Monte Produce, known primarily for its fresh fruit and vegetable business, now holds full global rights to the Del Monte brand...

Solaris Energy Infrastructure (SEI) has been drawing attention after rebranding from Solaris Oilfield Infrastructure in September 2024. The company is shifting its identity toward broader power and logistics solutions that span data centers, energy projects, and oilfield services. See our latest analysis for Solaris Energy Infrastructure. The share price has been volatile in the short term, with a 7 day share price return of 18.9% and a 1 day decline of 6.2%. The 1 year total shareholder...

Edgewise Therapeutics (EWTX) recently reported long term MESA extension data for its lead candidate sevasemten in Becker muscular dystrophy, showing functional stabilization over 3.5 years versus the decline typically seen in natural history data. See our latest analysis for Edgewise Therapeutics. The recent Becker muscular dystrophy data arrives after a strong run, with a 90 day share price return of 13.74% and a 3 year total shareholder return above 3x. However, the 1 month share price...

JD.com, ticker NasdaqGS:JD, has agreed a new partnership with BYD to build and expand fast charging electric vehicle stations across China. The collaboration combines JD.com's logistics footprint and office network with BYD's electric vehicle expertise to roll out charging sites at scale. The initiative extends JD.com beyond its core e commerce and delivery operations into EV infrastructure and related services. For JD.com, best known for its e commerce platform and nationwide logistics...

Earlier this month, EQT Corporation launched a cash tender offer of up to US$1.15 billion to repurchase several series of its outstanding senior notes and also disclosed plans to redeem all of its 6.500% Senior Notes due 2027. By retiring multiple tranches of bonds and potentially using both cash on hand and its revolving credit facility, EQT is actively reshaping its debt profile and interest burden. Next, we’ll explore how EQT’s move to pare back over US$1.15 billion of debt could affect...

What recent performance says about Lionsgate Studios shares Lionsgate Studios (LION) has drawn attention after recent trading, with the share price around $9.22 and returns spanning a 3.3% decline over 1 day and a 5.1% decline over the past week. Over the past month, the stock shows an 8.0% gain and about an 11.0% gain over the past 3 months. The year-to-date move is a modest 0.9% decline, giving investors a mixed short-term picture. See our latest analysis for Lionsgate Studios. Short term,...

If you are wondering whether Freeport-McMoRan’s current share price lines up with its underlying worth, this breakdown will help you connect the dots between market moves and valuation. The stock most recently closed at US$52.09, with returns of 31.2% over 1 year and 0.3% year to date, alongside shorter term moves of a 7.6% decline over 7 days and a 16.7% decline over 30 days that may reflect changing expectations or risk perceptions. Recent headlines around Freeport-McMoRan have focused on...

Joby Aviation (JOBY) has drawn fresh attention after recent trading left the stock around $9.23, with returns under pressure over the past month and the past 3 months. This has prompted investors to reassess expectations. See our latest analysis for Joby Aviation. At around $9.23, the recent 1 day and 7 day share price declines, along with a 30 day share price return of 8.52% and a 90 day share price return of 35.09%, contrast with a 1 year total shareholder return of 39.01% and a 3 year...

If you are wondering whether Visa's current share price offers good value or not, it helps to separate short term noise from what the market is really pricing in. Visa shares last closed at US$301.62, with returns of a 1.8% decline over 7 days, a 5.8% decline over 30 days, and a 12.9% decline year to date. The 1 year return sits at a 9.5% decline, alongside longer term gains of 39.6% over 3 years and 46.5% over 5 years. Recent coverage around Visa has focused on its role at the center of...

Why 3M Stock Is Drawing Attention Now 3M (MMM) has been on investors’ radars after a period where the share price showed negative returns over the past month and past 3 months, prompting fresh questions about how to think about the stock today. See our latest analysis for 3M. At around $141.20 per share, 3M’s recent 7 day and 30 day share price returns of 6.47% and 13.99% declines suggest fading short term momentum. However, the 3 year total shareholder return of 85.06% reflects a very...

Recent performance and valuation snapshot QCR Holdings (QCRH) has attracted fresh attention after recent share price moves, with the stock showing a 0.3% gain over the past day but an 11.3% decline over the past month. Over the past 3 months, the share price shows a 4.6% decline, while the 1 year total return stands at 14.1%. The 3 year total return is 8.8x, and the 5 year total return is 74.9%. See our latest analysis for QCR Holdings. At a share price of $81.62, QCR Holdings has seen short...

Investors may be wondering if Lattice Semiconductor at around US$88.62 is still good value after its strong run, or if the market has already priced in most of the opportunity. The stock has seen mixed recent returns, with a 3.3% gain over the last 7 days, an 8.9% decline over 30 days, and returns of 12.7% year to date and 46.1% over 1 year. These moves sit against a backdrop of ongoing interest in semiconductor names. Investors have been watching how companies like Lattice position their...

Wondering whether Progressive at around US$206 still offers value or is pricing in too much optimism? This article breaks down what the current share price could be implying. The stock has inched up 0.4% over the last 7 days and 1.3% over the last 30 days, although it is still showing a 2.9% decline year to date and a 19.6% decline over the last year, set against longer term returns of 60.6% over 3 years and 142.0% over 5 years. Recent coverage has focused on Progressive's position within...

Wondering if Brookfield Infrastructure Partners at around US$36.47 still offers value, or if most of the easy gains are already behind it? This article walks through the key numbers so you can judge that for yourself. The unit price has been mixed in the short term, with a 3.4% decline over the last week and a 4.7% decline over the last month, but it still sits on a 6.3% year to date gain and a 33.5% return over the past year. Recent attention on Brookfield Infrastructure Partners has...

Many investors are asking whether Nextpower is still attractively priced after its strong recent run, or whether most of the easier gains may already have been realized. The stock recently closed at US$114.39, with returns of 23.3% year to date and 158.4% over the last year. Over the past week and month, however, it has declined 4.4% and 1.4%, respectively. Recent coverage has focused on how the 1-year return of 158.4% compares with longer term performance of 266.6% over 3 years, providing...

If you are wondering whether CBIZ's share price now reflects its true worth, the starting point is understanding how that price lines up against different measures of value. The stock recently closed at US$27.02, with returns of 3.4% over the last week, a 9.5% decline over the past month, and longer term returns of a 46.8% decline year to date and a 63.0% decline over the past year. These moves sit against a backdrop where investors have been reassessing many professional services names,...

On March 19, 2026, Guggenheim initiated coverage of Automatic Data Processing (ADP) with a Buy rating as management raised its fiscal 2026 revenue and adjusted EPS growth outlook on the Q4 2025 earnings call. This combination of fresh analyst coverage and upgraded guidance highlights how ADP’s diversified business mix may help address investor concerns about AI-related pressures on software vendors. We’ll now examine how ADP’s upgraded 2026 outlook, underpinned by share repurchases,...

KLA Corporation recently raised its quarterly dividend to US$2.30 per share from US$1.90 and expanded its share repurchase authorization by US$7.00 billion to a total of US$20.00 billion, marking its 17th consecutive annual dividend increase. These larger cash returns to shareholders highlight KLA's confidence in its cash generation and capital allocation framework at a time of accelerating AI-related demand. Next, we’ll explore how KLA’s richer dividend and expanded buyback program reshape...

Seabourn, Carnival Corporation's ultra luxury brand, has introduced a highlighted lineup of high profile guest speakers for its 2027 World Cruise. The speakers will feature within Seabourn Conversations, the brand's enrichment program focused on curated onboard talks and experiences. This programming update is positioned as a material upgrade to the 2027 World Cruise offering, aligned with Carnival's premium, experience driven cruise strategy. For investors following NYSE:CCL, this move...

AeroVironment (NasdaqGS:AVAV) recently featured on a major U.S. news program for its laser defense systems aimed at countering international drone threats. The company secured more than US$1b in new long term defense contracts, significantly expanding its backlog. These wins arrived alongside a record goodwill impairment and financial guidance that some investors viewed as underwhelming. AeroVironment is best known for unmanned aerial systems, and its advanced laser defense technology...

Pathward Financial recently reported a softer quarter in which revenue and net interest income came in below analysts’ expectations, prompting investors to reassess its recent performance. Despite the miss, CEO Brett Pharr reiterated confidence in Pathward’s banking‑as‑a‑service strategy and signaled an emphasis on sustainable growth heading into fiscal 2026. We’ll now examine how the earnings miss, alongside management’s reaffirmed confidence, may reshape Pathward Financial’s longer-term...

If you are wondering whether Regeneron Pharmaceuticals at around US$732.87 is still offering value or starting to look expensive, you are asking the right question. The stock has seen mixed returns, with an 11.9% gain over the last year but declines of 1.7% over the past week, 6.3% over the past month, and 5.6% year to date. These moves can change how the market views its growth potential and risk. Recent coverage of Regeneron Pharmaceuticals has kept attention on the business and its...